Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 170 results found. Search for [ combination drugs ]

Results 1 to 21 of 170
BusinessToday.In
January 18, 2021
Stocks to watch today on January 18: HCL Tech, InterGlobe Aviation, SpiceJet, Vedanta, Wipro, DHFL, JBM Auto among others are the top stocks to watch out for in Monday's trading session


BusinessToday.In
December 1, 2020
Dr. Reddy's and RDIF had partnered up in September 2020, so as to conduct clinical trials of the Sputnik V vaccine, as well as having the rights for distribution of its first 100 million doses in India.


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


BusinessToday.In
October 17, 2020
India participated in the trials too. In a statement issued on Friday, ICMR concluded the same and said there were no benefits of remdesivir in any of the patients


Reuters
October 16, 2020
The American company said the data appeared inconsistent, the findings were premature and that other studies had validated the drug's benefits


BusinessToday.In
October 16, 2020
The WHO said that the Solidarity trial looked at the effects of these treatments on overall mortality, initiation of ventilation, and duration of hospital stay in hospitalised patients


Reuters
October 9, 2020
Lilly had previously said it would make one million doses of its single antibody treatment available by the end of the year


BusinessToday.In
October 8, 2020
Last month, Hetero became the first Indian drug company to launch Favipiravir in 800/200mg dosage for the treatment of mild-to-moderate symptomatic Covid-19 patients


PTI
October 7, 2020
The COVID-19 pandemic is estimated to push an additional 88 million to 115 million people into extreme poverty this year, with the total rising to as many as 150 million by 2021


BusinessToday.In
August 6, 2020
Coronavirus treatment: With the 400 mg FabiFlu, patients could undergo a more relaxed dosage. The company said that reducing pill burden has been a demand from doctors and patients alike


Reuters
July 31, 2020
Gilead's second-quarter sales fell nearly 10% from a year earlier to $5.1 billion, short of the average analyst estimate of $5.3 billion, according to Refinitiv


Associated Press
July 20, 2020
For months before studies like these, learning what helps or harms has been undermined by \"desperation science\" as doctors and patients tried therapies on their own or through a host of studies not strong enough to give clear answers


BusinessToday.In
July 13, 2020
Glenmark has also started a post-marketing surveillance study on FabiFlu in 1,000 patients to assess its efficacy and safety


Reuters
July 5, 2020
The UN agency said that the decision, taken on the recommendation of the trial's international steering committee, does not affect other studies where the drugs are used for non-hospitalised patients or as prophylaxis


BusinessToday.In
July 3, 2020
On June 23, Patanjali Ayurveda had launched 'Coronil' and 'Swasari'. It had claimed that these two drugs could be used for treating COVID-19 and had successfully treated 100 per cent of the COVID-19 patients it was administered to in clinical trials


BusinessToday.In
July 3, 2020
Stock Market LIVE Updates on July 3: Bajaj Auto, followed by Asian Paints, Bharti Airtel, HUL, Reliance Industries, HUL and Kotak Bank were among the top gainers in the Sensex pack. On the contrary, Tata Steel, HDFC, M&M and Bajaj Finance were among the laggards


BusinessToday.In
June 29, 2020
Cipla share price rose up to 2.1% to Rs 648 against earlier close of Rs 634.70 on BSE


BusinessToday.In
New Delhi, June 20, 2020
Company says Favipiravir is backed by strong clinical evidence showing encouraging results in patients with mild to moderate COVID-19; can offer a rapid reduction in viral load in four days and provide faster symptomatic and radiological improvement


PB Jayakumar
June 11, 2020
While two such therapies have entered the human clinical trial phase, more are expected in the coming weeks


Reuters
June 11, 2020
Lilly is also doing preclinical studies of a third antibody treatment for the illness caused by the new coronavirus that could enter human clinical trials in the coming weeks, Chief Scientific Officer Daniel Skovronsky said


PAGES 1 OF 9  12345